The association between NAFLD and risk of chronic kidney disease: a cross-sectional study

Código QR

The association between NAFLD and risk of chronic kidney disease: a cross-sectional study

Objective: The aim of this study was to evaluate the association between nonalcoholic fatty liver disease (NAFLD) and NAFLD with different comorbidities and risk of chronic kidney disease (CKD) and abnormal albuminuria. Materials and Methods: A total of 3872 Chinese individuals excluding those with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ying Cao, You Deng, Jingjing Wang, Hong Zhao, Jingyu Zhang, Wen Xie
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/39e9065d1081459eb92192b66e7838fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
por: Kose E, et al.
Publicado: (2014)

Interventions performed by community pharmacists in one Canadian province: a cross-sectional study
por: Young SW, et al.
Publicado: (2012)

Chronic hepatitis C: future treatment
por: Wendt A, et al.
Publicado: (2014)

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study
por: François Riglet, et al.
Publicado: (2020)

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
por: Gillian W Reierson, et al.
Publicado: (2009)

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
por: Michael A. Tortorici, et al.
Publicado: (2021)

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
por: Ekaterina Gibiansky, et al.
Publicado: (2021)

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015)

Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group
por: Timothé Ménard, et al.
Publicado: (2021)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno K, et al.
Publicado: (2013)

Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
por: Sabrina Zora, et al.
Publicado: (2021)

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Solène M. Laville, et al.
Publicado: (2021)

CKD subpopulations defined by risk‐factors: A longitudinal analysis of electronic health records
por: Rajagopalan Ramaswamy, et al.
Publicado: (2021)

Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
por: Ine Skottheim Rusten, et al.
Publicado: (2021)

Effect of Lower Limb Muscle Fatigue on Fall Risk for Transfemoral Amputee: A Pilot Study
por: Mohd Khairuddin Mohd Safee, et al.
Publicado: (2021)

Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients
por: Savannah J. McFeely, et al.
Publicado: (2021)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease
por: Heather&nbsp;E Vezina, et al.
Publicado: (2009)

What Would Become of Nuclear Risk if Governments Changed Their Regulations to Recognize the Evidence of Radiation’s Beneficial Health Effects for Exposures That Are Below the Thresholds for Detrimental Effects?
por: Jerry M. Cuttler, et al.
Publicado: (2021)

Retraction notice to 'Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2' [Biomed. Pharmacother. 95 (2017) 1129–1138]
por: Wen Li, et al.
Publicado: (2021)

Corrigendum to: ‘Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice’ [Biomed. Pharmacother. 114 (2019) 108804]
por: Xiao-Lei Ma, et al.
Publicado: (2021)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii T, et al.
Publicado: (2021)

Retraction Notice to: Silencing lncRNAs PVT1 UpregulatesmiR-145 and Confers Inhibitory Effectson Viability, Invasion, and Migration in EC
por: Si-Ning Shen, et al.
Publicado: (2021)

In Reference to Risk Perception of Septic Shock with Multiple Organ Failure Due to Acute Exacerbation of an Infectious Dental Disease [Letter]
por: Baba Y, et al.
Publicado: (2021)

Retraction Notice to: miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo
por: Chengliang Yang, et al.
Publicado: (2021)

Proteomic analysis reveals rotator cuff injury caused by oxidative stress
por: Tao Yuan, et al.
Publicado: (2021)

Can acid exposure time replace the DeMeester score in the diagnosis of gastroesophageal reflux-induced cough?
por: Yiqing Zhu, et al.
Publicado: (2021)

circHMCU Promotes Proliferationand Metastasis of Breast Cancerby Sponging the let-7 Family
por: Xiaojin Song, et al.
Publicado: (2021)

Markers of Chronic Inflammation in Overweight and Obese Individuals and the Role of Gender: A Cross-Sectional Study of a Large Cohort
por: Cohen E, et al.
Publicado: (2021)

Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
por: Alfredo G. Casanova, et al.
Publicado: (2021)

Exploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network Pharmacology
por: Chen Yong, et al.
Publicado: (2021)

Chronic Intractable Pruritus in Chronic Kidney Disease Patients: Prevalence, Impact, and Management Challenges — A Narrative Review
por: Świerczyńska K, et al.
Publicado: (2021)

Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling
por: Heajin Jun, et al.
Publicado: (2020)

Modern approaches to pharmacotherapy of tuberculosis infection in children
por: Vasiliy E. Novikov, et al.
Publicado: (2021)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Is antibiotics overuse justified when immediate intervention is not possible? A rapid evidence review
por: Nour Ibrahim, et al.
Publicado: (2021)

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
por: Ata Mahmoodpoor, et al.
Publicado: (2020)

Book of Abstracts 38th Technology Days 9th and 10th September 2021
por: Molitorisová M.
Publicado: (2021)

Optimal management of Barrett&#39;s esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)